Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke
NCT05421533 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 705
Last updated 2024-12-03
Summary
The GARDENIA registry will collect real-world clinical data on the anticoagulant strategies in patients with AF at elevated risk of stroke but also elevated risk of bleeding.
Conditions
Sponsors & Collaborators
-
CYTE Global
collaborator NETWORK -
Anthos Therapeutics, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-14
- Primary Completion
- 2024-09-30
- Completion
- 2024-09-30
Countries
- United States
- Argentina
- Brazil
- Canada
- Czechia
- Germany
- Hungary
- Italy
- Mexico
- Poland
- Spain
- United Kingdom
Study Locations
More Related Trials
-
Global Anticoagulant Registry in the Field
NCT01090362 ·Status: COMPLETED
-
Progression of Atrial Fibrillation in the Young
NCT05080712 ·Status: RECRUITING
-
Prevention Of Recurrence Of Atrial Fibrillation
NCT00041496 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)
NCT03508258 ·Status: WITHDRAWN
-
Catheter Versus Thoracoscopic Surgical Ablation Strategy in Persistent Atrial Fibrillation
NCT01385358 ·Status: UNKNOWN ·Phase: NA
-
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
NCT05293080 ·Status: RECRUITING ·Phase: PHASE3
-
Cardiovascular Risk Reduction in Atrial Fibrillation Trial
NCT04347330 ·Status: RECRUITING ·Phase: NA
-
Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305
NCT00915356 ·Status: COMPLETED ·Phase: PHASE2
-
Atrial Pacing for Termination and Prevention of Atrial Fibrillation
NCT00123344 ·Status: COMPLETED ·Phase: NA
-
The Influence of Genetic Predisposition on Outcome After Catheter Ablation of Atrial Fibrillation.
NCT04753541 ·Status: UNKNOWN
-
Computerized Decision Support to Prevent Stroke in Atrial Fibrillation
NCT06355986 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach
NCT02654353 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
NCT02839304 ·Status: COMPLETED ·Phase: NA
-
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
NCT04160000 ·Status: RECRUITING ·Phase: PHASE4
-
Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control
NCT06833138 ·Status: RECRUITING ·Phase: NA
-
Substrate Guided Ablation Therapy for Atrial Fibrillation
NCT04657978 ·Status: UNKNOWN
-
Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study
NCT03186976 ·Status: COMPLETED ·Phase: NA
-
Secondary Prevention of Atrial Fibrilation
NCT03259893 ·Status: TERMINATED ·Phase: NA
-
Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
NCT06783868 ·Status: NOT_YET_RECRUITING
-
Atrial Fibrillation Characterization on Paroxysmal and Persistent Patients
NCT05343923 ·Status: COMPLETED
-
Safety of Cardioversion of Acute Atrial Fibrillation
NCT01380574 ·Status: COMPLETED
-
Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention
NCT06735001 ·Status: RECRUITING ·Phase: NA
-
Association of Genetic Polymorphisms With Atrial Fibrosis and Thrombogenic Substrate in Patients With Non-valvular Atrial Fibrillation
NCT03560219 ·Status: UNKNOWN
-
Substrate Remodelling and Targeted Ablation in AF
NCT07047235 ·Status: RECRUITING ·Phase: NA
-
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
NCT01661205 ·Status: COMPLETED ·Phase: NA